Skip to Main Content

Paper Details

Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
Acad Emerg Med
9
2015
CAD, Chest pain, MR-proADM, Midregional proadrenomedullin, acute myocardial infarction, cTnI, chest pain, coronary artery disease, heart failure, hypertension, midregional proadrenomedullin, patients, troponin, unstable angina
Author NameAffiliation
Christian MuellerUniversity Hospital Basel
Robert H ChristensonUniversity of Maryland
James McCord
Richard Nowak
Lori B DanielsUniversity of California
Judd E HollanderThomas Jefferson University
Donald SchreiberStanford University School of Medicine
Christopher R deFilippiUniversity of Maryland
Christopher HoganVirginia Commonwealth University
Deborah B DiercksUniversity of California, Davis Medical Center
Alexander T LimkakengDuke University Medical Center
Alan H B WuUniversity of California san francisco
Paul CloptonVeterans Affairs Medical Center
William F PeacockBaylor College of Medicine
Alan S MaiselUniversity of California
Alan S MaiselVeterans Affairs Medical Center
  • 1 - 16

Datasets

Release 1.2